Results 41 to 50 of about 260 (85)

Purpuric rash due to epsilon-aminocaproic acid. [PDF]

Br Med J, 1980
Chakrabarti A, Collett KA.
europepmc   +1 more source

Effect of gamma aminobutyric acid on the carbon dioxide rebreathing response of normal subjects: a study using vigabatrin. [PDF]

Thorax, 1990
Fennerty AG, Rimmer EM, Boulton J, Richens A.   +3 more
europepmc   +1 more source

Use of antiepileptic drugs in childhood epilepsy. [PDF]

Arch Dis Child, 1991
O'Donohoe NV.
europepmc   +1 more source

Effects of long term vigabatrin on somatosensory evoked potentials in epileptic patients. [PDF]

Br J Clin Pharmacol, 1989
Liegeois-Chauvel C, Marquis P, Gisselbrecht D, Pantieri R, Beaumont D, Chauvel P.   +5 more
europepmc   +1 more source

Evaluation of vigabatrin as an add-on drug in the management of severe epilepsy. [PDF]

J Neurol Neurosurg Psychiatry, 1990
Sander JW, Trevisol-Bittencourt PC, Hart YM, Shorvon SD.   +3 more
europepmc   +1 more source

Vigabatrin and depression. [PDF]

J Neurol Neurosurg Psychiatry, 1993
Ring HA, Crellin R, Kirker S, Reynolds EH.   +3 more
europepmc   +1 more source

Effects of penicillins and 6-aminohexanoic acid on the kinetics of human plasmin. [PDF]

Biochem J, 1989
Higazi AA, Mayer M.
europepmc   +1 more source

Proceedings: A therapeutic trial of epsikapron. [PDF]

J Neurol Neurosurg Psychiatry, 1975
So SC, Sengupta RP.
europepmc   +1 more source

Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats.

J Appl Physiol (1985), 2009
Kim JH, Bugaj LJ, Oh YJ, Bivalacqua TJ, Ryoo S, Soucy KG, Santhanam L, Webb A, Camara A, Sikka G, Nyhan D, Shoukas AA, Ilies M, Christianson DW, Champion HC, Berkowitz DE.   +15 more
europepmc   +1 more source

Clinical pharmacology of vigabatrin. [PDF]

Br J Clin Pharmacol, 1989
Schechter PJ.
europepmc   +1 more source